This inventor holds 1 USPTO granted patent. Top assignee: The Genetics Company, Inc.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Cornelia Marty-Ernst: Innovator in Medicinal Chemistry
Introduction
Cornelia Marty-Ernst is a notable inventor based in Binz, Switzerland. She has made significant contributions to the field of medicinal chemistry, particularly through her innovative work on sulfonamide compounds. Her research focuses on the development of new medicaments, especially for the treatment of cancer.
Latest Patents
Cornelia holds a patent for "Sulfonamides and their use as a medicament." This invention relates to the use of a sulfonamide compound with a specific formula, which includes various functional groups that enhance its medicinal properties. The patent emphasizes the potential of these compounds in treating cancer, showcasing her commitment to advancing healthcare through innovative solutions. She has 1 patent to her name.
Career Highlights
Cornelia is associated with The Genetics Company, Inc., where she applies her expertise in medicinal chemistry. Her work has been instrumental in developing new therapeutic agents that can significantly impact patient care. Her dedication to research and innovation has positioned her as a key figure in her field.
Collaborations
Cornelia collaborates with esteemed colleagues, including Gabriel Garcia and Pierre Daram. These partnerships enhance her research efforts and contribute to the advancement of medicinal chemistry.
Conclusion
Cornelia Marty-Ernst exemplifies the spirit of innovation in the field of medicinal chemistry. Her contributions through patents and collaborations highlight her commitment to improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile